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Abstract: Constructs intended for bone tissue engineering (TE)
are influenced by the initial cell seeding density. Therefore, the
objective of this study was to determine the effect of bone mar-
row stromal stem cells (BMSCs) density loaded onto copolymer
scaffolds on bone regeneration. BMSCs were harvested from
rat’s bone marrow and cultured in media with or without osteo-
genic supplements. Cells were seeded onto poly(L-lactide-co-e-
caprolactone) [poly(LLA-co-CL)] scaffolds at two different den-
sities: low density (1 3 106 cells/scaffold) or high density (2 3
106 cells/scaffold) using spinner modified flasks and examined
after 1 and 3 weeks. Initial attachment and spread of BMSC onto
the scaffolds was recorded by scanning electron microscopy.
Cell proliferation was assessed by DNA quantification and cell
differentiation by quantitative real-time reverse transcriptase-
polymerized chain reaction analysis (qRT-PCR). Five-millimeter
rat calvarial defects (24 defects in 12 rats) were implanted with
scaffolds seeded with either low or high density expanded with
or without osteogenic supplements. Osteogenic supplements
significantly increased cell proliferation (p < 0.001). Scaffolds
seeded at high cell density exhibited higher mRNA expressions
of Runx2 p5 0.001, Col1 p5 0.001, BMP2 p<0.001, BSP
p<0.001, and OC p5 0.013. More bone was formed in response
to high cell seeding density (p5 0.023) and high seeding density
with osteogenic medium (p5 0.038). Poly (LLA-co-CL) scaffolds
could be appropriate candidates for bone TE. The optimal num-
ber of cells to be loaded onto scaffolds is critical for promoting
Extracellular matrix synthesis and bone formation. Cell seeding
density and osteogenic supplements may have a synergistic
effect on the induction of new bone.VC 2015 Wiley Periodicals, Inc. J
BiomedMater Res Part A: 103A: 3649–3658, 2015.
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INTRODUCTION
Aliphatic polyesters such as poly(lactide), poly(lactide-co-
glycolide), and poly(e-caprolactone) and their synthesized
copolymers are the most common synthetic biodegradable
polymers used as scaffolding in bone tissue engineering
(TE). By copolymerization of e-caprolactone with different
lactones, the physical and mechanical properties of the poly-
esters can be tailored, extending the range of applications of
scaffolds.1 Poly(L-lactide-co-e-caprolactone) [poly(LLA-co-
CL)] possesses appropriate mechanical and physical proper-
ties. Not only the degradation rate but also the shape of the
scaffolds can readily be modiﬁed.2–4 Moreover, animal stud-
ies have conﬁrmed that endothelial microvascular networks
can be created in porous scaffolds of 3D copolymer and sus-
tained after implantation.5
In developing TE constructs which may inﬂuence the
features and functionality of the engineered tissues, cell
seeding density is a critical factor. The optimal seeding den-
sity of a scaffold depends on the scaffold biomaterial, the
structure of the scaffold, and the seeding technique.6,7 The
inﬂuence of cell seeding density on TE constructs has been
studied in cardiac tissue, cartilage, and bone.8–10 In bone
TE, cell seeding density inﬂuences cell proliferation, distri-
bution, differentiation, extracellular matrix (ECM) synthesis,
and tissue formation.11–16 It has been reported that bone
marrow stromal cells (BMSCs), cultured at density of 6.83
3 105 cells/cm2 in three-dimensional (3D) poly(DL-lactic-co-
glycolic acid) scaffolds, exhibited rapid proliferation over
the ﬁrst 7 days.17 Increasing the number of BMSCs from
3.54 3 104 to 3.54 3 105 cells/cm2 promoted osteogenic
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expression in titanium mesh.18 Similarly, Zhou et al.
demonstrated that the total number of cells loaded onto
polycaprolactone\tricalciumphosphate scaffolds signiﬁcantly
inﬂuenced the production of ALP and osteocalcin.19 In rab-
bit segmental bone defect it was shown that a density of
1.5 3 106 cells/scaffold stimulated bone deposition after 2
weeks.20 However, another study reported that an increase
in cell seeding density from 1 to 6 3 106 cells/mL did not
enhance bone formation, but promoted more homogenous
cell distribution throughout the constructs.21 Further, in vivo
studies on cartilage and bone formation have failed to dem-
onstrate any signiﬁcant effects of high cell seeding density
in 3D porous scaffolds.9,22 The inconclusive results indicate
the need for further evaluation of the in vitro and in vivo
effects of cell seeding density.
BMSCs have been widely used and investigated because
they can be expanded in vitro and differentiated into a vari-
ety of cell types such as adipocytes, chondrocytes, myoblasts,
and osteoblasts, by supplementing the cell culture medium
with speciﬁc growth and differentiation factors.23–25 Osteo-
genic differentiation of BMSCs can be induced by the
introduction of supplements such as ascorbic acid, dexameth-
asone, and b-glycerophosphate into the culture medium.26,27
It has been reported that preculture of BMSCs in osteogenic
medium for a short period may promote osteogenesis.28 On
the other hand, a published study demonstrated that osteoge-
netic activity is signiﬁcantly higher in non-preculture of
BMSCs.29 These contradictory ﬁndings indicate that the
in vivo effect of osteogenic medium needs to be further
addressed.
The main objective of this study was to assess the osteo-
genic potential of a tissue-engineered construct of BMSCs
and poly(LLA-co-CL) scaffolds in vitro and in vivo, using the
critical size defect model. A further objective was to deter-
mine the effect of low and high seeding density of BMSCs,
cultured with and without osteogenic supplements, on cell
proliferation and differentiation and on bone formation. The
synergistic effect of seeding density and osteogenic supple-
ments was also studied.
MATERIALS AND METHODS
Preparation of polymer scaffolds
Copolymer poly(LLA-co-CL) material was synthesized as
previously described.30 In brief, monomer, initiator, and cat-
alysts were weighed inside a glove box and bulk polymer-
ized at 1108C for 72 h, then precipitated three times in cold
hexane and methanol. Porous scaffolds were produced from
the copolymer using a solvent-casting-particulate-leaching
method. The pore size was >90 lm and the porosity 90%.
After leaching of salt particles, the scaffolds were dried and
sterilized in an inert atmosphere using electron beam radia-
tion at a dose of 2.5 Mrad from a pulsed electron accelera-
tor (Mikrotron, Acceleratorteknik, Stockholm, Sweden) at
6.5 MeV.
Cell isolation
Bone marrow stromal cells (BMSCs) were isolated from the
femurs of two donor Lewis rats and maintained by a modiﬁ-
cation of a method previously described.31 The animals
were housed under uniform conditions for at least 1 week
before the experiment, then euthanized by an overdose of
carbon dioxide (CO2) inhalation. The femurs were retrieved,
cleaned, and washed three times for 5 min in phosphate-
buffered saline (PBS) supplemented with 3% penicillin–
streptomycin (PS). The metaphyseal ends of the femurs
were cut off, and the marrow cavity was ﬂushed with mini-
mum essential medium (aMEM, InvitrogenTM, Carlsbad, CA)
supplemented with 1% PS and 15% fetal bovine serum
(FBS) into a sterile falcon tube. The cells were centrifuged
and resuspended in fresh a-MEM medium containing 15%
FBS and plated in culture ﬂasks (NUNC A/S, Roskilde, Den-
mark). The medium was changed the next day, with fresh
aMEM medium containing 1% PS and 10% FBS. Cells were
cultured in aMEM 1% AB and 10% FBS until they reached
80% conﬂuence, after which they were passaged. Passages
3–5 were used for the in vitro studies and passages 3 and 4
for the in vivo studies. Half of the cells were cultured in
aMEM only, supplemented with 1% PS and 10% FBS. For
the other half, the culture medium was supplemented with
osteogenic factors [100 nM dexamethasone (dex), 10 mMb
glycerophosphate, and 0.05 mM ascorbic acid]11,32 7 days
before the experiments.
The study was approved by the Norwegian Animal
Research Authority and conducted according to the Euro-
pean Convention for the Protection of Vertebrates Used for
Scientiﬁc Purposes (local approval number 20124903).
Scanning electron microscopy
The poly(LLA-co-CL) scaffolds with BMSCs seeded at differ-
ent densities were examined under scanning electron
microscopy (SEM) to determine cell adhesion and spreading.
After 7 and 21 days of culture, samples were prepared for
SEM as follows; ﬁrst, the medium was replaced with 2.5%
glutaraldehyde in a-MEM without serum and ﬁxed for 30
min at room temperature. Second, samples were ﬁxed in
2.5% glutaraldehyde in 0.1M sodium cacodylate pH 7.2 with
0.1M sucrose for 30 min at room temperature. The samples
were then treated with 1% osmium tetroxide in distilled
water for 1 h, followed by dehydration through a graded
series of ethanol solutions (70, 80, 95, and 100%), critical-
point-dried (using CO2 as transitional ﬂuid and the speci-
mens mounted on aluminum holders), and sputter-coated
with a 10 nm conducting layer of gold platinum. Finally, the
samples were examined by SEM (Jeol JSM 7400F, Tokyo,
Japan) using a voltage of 10 kV.
DNA quantiﬁcation of cell proliferation
DNA quantiﬁcation was carried out as described previously,
with some modiﬁcations,33 using reagents from the Master-
PureTM Complete DNA and RNA Puriﬁcation Kit (EpicentreV
R
Biotechnologies, Madison, WI). The amount and purity of
DNA per scaffold (n5 4 scaffolds for each group and time
point) were measured by optical densitometry at 260 and
280 nm, using a Nanodrop ND 1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE).
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Real-time reverse transcription-polymerase chain
reaction analysis
RNA isolation and RT-PCR were performed as described pre-
viously.32 Brieﬂy, total RNA was collected from cells grown
onto the scaffolds (n54 scaffolds for each group and time
point) using an isolation kit (E.Z.N.AVR, Omega Bio-Tek, Nor-
cross, GA) according to the manufacturer’s protocol. RNA
purity and quantiﬁcation were determined by spectropho-
tometry (NanoDrop Spectrophotometer, NanoDrop Technolo-
gies). Real-time reverse transcription-polymerase (RT-PCR)
was conducted under standard enzyme and cycling condi-
tions on a StepOneTM real-time PCR system, using TaqManVR
gene expression assays (Applied BiosystemsTM, Carlsbad,
CA): runt-related transcription factor 2 (Runx2), collagen
type I (Col I), alkaline phosphatase (ALP), bone morphoge-
netic protein 2 (BMP2), bone sialoprotein (BSP), osteocalcin
(OC), and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). The data were analyzed using a comparative Ct
method by StepOne. Expression levels of the genes were
normalized to the Housekeeper index with GAPDH serving
as the endogenous control.
Graft preparation
Poly (LLA-co-CL) scaffolds were placed at the bottom of
wells in 96-well plates, prewet with the culture media, and
incubated at 378C and 5% CO2 overnight. The following
morning, BMSCs were trypsinized from the culture ﬂasks
and seeded on the top of each scaffold, at low density (1 3
106 cells/scaffold) or high density (2 3 106 cells/scaffold).
An orbital shaker (EppendorfVR, Hamburg, Germany) was
applied to facilitate the distribution of the cells from the
surface of the scaffold into the pores.6 The cell/scaffold
grafts were incubated for 3 h for cell attachment and then
transferred either to rat calvarial bone defects (n5 12 rats)
for 8 weeks or to four separate spinner ﬂasks (Wheaton Sci-
ence, Millville, NJ).32 The spinner ﬂasks were placed on a
magnetic stirrer (Stem Stirrer, UK) and the side arm caps
kept loose. The grafts were separated by spacers made of
silicone tubes and cultured in a CO2 incubator for 3 weeks.
Surgical procedure and implantation
Twelve male Lewis rats (2.5 months old, weight: 300–
350 g) were kept in the animal facility for 1 week to accli-
matize to diet, water, and housing, under a 12 h/12 h light/
dark cycle. The rats were anesthetized with isoﬂuorane
(Isoba vetVR, Schering Plough, Kenilworth, NJ) in combina-
tion with NO2 and O2, using a custom-made mask. The sur-
gical site was shaved and scrubbed with 70% alcohol. Using
sterile instruments and an aseptic technique, a 2-cm antero-
posterior cranial skin incision was made along the midline.
The subcutaneous tissue, musculature, and periosteum were
dissected and reﬂected to expose the calvaria. A full-
thickness defect (5 mm in diameter) was created in the cen-
tral area of each parietal bone, using a saline-cooled tre-
phine drill to prevent overheating of the bone margins and
to remove the bone debris. The dura mater was left undis-
turbed. Twenty-four defects were implanted with disc-
shaped scaffolds of poly(LLA-co-CL), 5 mm in diameter 3
1.5 mm height, seeded with high or low cell density using
two cell culture environment: in medium with or without
osteogenic supplements. Accordingly, the scaffolds were
classiﬁed into four different groups:
i. Six defects implanted with scaffolds seeded with cells in
low density without osteogenic supplements (LD-OM).
ii. Six defects implanted with scaffolds seeded with cells in
high density without osteogenic supplements (HD-OM).
iii. Six defects implanted with scaffolds seeded with cells in
low density with osteogenic supplements (LD1OM).
iv. Six defects implanted with scaffolds seeded with cells in
high density with osteogenic supplements (HD1OM).
The periosteum and skin were repositioned and stabi-
lized with sutures (Vicryl Plus 4-0). Topical antibiotic Baci-
mycine (Bacitracin ointment) was applied to the wound to
prevent postoperative infection. All animals were given an
intramuscular dose of Buprenorphine (TemgesicV
R
0.3 mg\kg)
as an analgesic and allowed to recover. The status of the
surgical wound, food intake, activity, and signs of infection
were monitored daily. After 8 weeks, the animals were
sacriﬁced by inhalation of CO2 and the calvarial defects with
surrounding bone and soft tissue were harvested for
subsequent evaluation.
X-ray micro-computed tomography
For quantitative evaluation of new bone formation in the rat
calvarial defects at 8 weeks, micro-computed tomography
(lCT) scans were taken using the SkyScan1172VR microfo-
cus X-ray system (SkyScanVR, Kontich, Belgium) with the
CTAn 1.8VR and NRECON RECONSTRUCTIONVR CT software
(SkyScanVR), as previously described.34 A 0.5-mm aluminum
ﬁlter was used to optimize the images. Source voltage and
current were set at 50 kV and 200 lA, respectively. After
operating CTAn 1.8VR to each reconstructed BMP ﬁles, bone
volume (BV), tissue volume (TV), and bone volume/tissue
volume (BV/TV) values were obtained.
Histology
Specimens for histological examination were ﬁxed with 4%
paraformaldehyde (Merck, White House Station, NJ) and
decalciﬁed for 4 weeks, using 10% ethylenediaminetetraace-
tic acid (EDTA) in 0.1M Tris buffer and 7.5% polyvinylpyr-
rolidone (PVP) (Merck). The specimens were then washed
in PBS, embedded in parafﬁn, and serially sectioned using a
microtome (HM 325, Thermo Scientiﬁc). The sections, 4–6
lm thick, were mounted on glass slides, deparafﬁnized,
hydrated by the application of xylene and alcohol in series,
and stained with Masson’s Trichrome (MT).
Statistical analysis
Sixteen scaffolds were available for the statistical analyses.
From each scaffold four measures were taken: two at day 7
and 2 at day 21. Twelve rats were included in the in vivo
analysis. To provide more accurate data of the hierarchical
structure of the outcome variables a multilevel modeling
analysis was applied. For the PCR statistical analyses,
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reference values were ﬁrst calculated for the low seeding
densities without osteogenic medium, for day 7 and day 21,
respectively. This was done for all the expression measures.
A random effect model with each particular gene as the ran-
dom factor (to control for the two repeated measures for
each gene) was applied. The reference value was deﬁned as
the predicted mean from these models. DCt values for each
gene were thereafter calculated as the difference between
the gene measures and the reference values. The DDCt val-
ues for all the expressions were then analyzed in linear
models using robust variance estimates to control for the
repeated measures for each particular gene. Mean values,
standard deviations, and 95% conﬁdence intervals were
estimated from these models. For low seeding densities
without osteogenic medium the mean values are by deﬁni-
tion “0.” For DNA and the lCT the measured values were
used directly in the analyses.
The effects were tested hierarchically. First the main
effects of seeding density, osteogenic medium, and days
were tested. Thereafter, a model including the ﬁrst-order
interaction was performed (densities*medium, medium*-
days, density*days), and then a model including the second-
order interaction (densities*medium*days). The lCT obser-
vations were measured at only one time point. This analytic
approach will correspond to performing repeated measures
analyses of variance. The statistical package StataIC version
13 was used to analyze the data. The p-values less than
0.05 were considered statistically signiﬁcant.
RESULTS
SEM analysis
Scaffolds with low and high cell seeding densities preincu-
bated in different media demonstrated good cellular attach-
ment at day 7 and day 21. The cells appeared to be
ﬂattened and well spread, covering the surface of the scaf-
folds and migrating into the inner pores of the scaffolds
(Fig. 1).
Cell proliferation
Osteogenic medium and incubation time showed a signiﬁ-
cant overall positive effect on the quantity of DNA
(p50.001), whereas cell seeding density showed no overall
effect (p5 0.32). There was a signiﬁcant relationship
between osteogenic medium and incubation time
(p50.001). The pairwise comparison at day 7 showed a
signiﬁcant stimulating effect of high cell seeding density
with osteogenic medium on the amount of DNA compared
with low cell seeding density with osteogenic medium
(p50.039). Similarly, high cell seeding density with osteo-
genic medium signiﬁcantly stimulated the amount of DNA
compared with high cell seeding density without osteogenic
medium (p< 0.001). For the pairwise comparison at day 21,
signiﬁcantly higher amounts of DNA were detected for high
cell seeding density with osteogenic medium than for high
cell seeding density without osteogenic medium (p<0.001)
(Fig. 2).
RT-PCR
Runx2 expression exhibited signiﬁcant overall upregulation
in relation to high cell seeding density (p5 0.001) and sig-
niﬁcant overall downregulation in relation to osteogenic
medium (p5 0.005). There were signiﬁcant interactions
between high cell seeding density and incubation time
(p50.042) and between high cell seeding density and
osteogenic medium (p50.046). The pairwise comparison at
day 7 revealed a signiﬁcantly higher expression of Runx2
for scaffolds with high cell seeding density with osteogenic
medium compared with low cell seeding density with osteo-
genic medium (p5 0.042). By day 21, Runx2 expression had
increased signiﬁcantly for high cell seeding density without
FIGURE 1. SEM images of scaffolds 1 week (1W) (A–D) and 3 weeks (3W) (E–H) after seeding with cultured BMSCs. A and E: Low cell seeding
density with cells preincubated with osteogenic medium. B and F: High cell seeding density with cells preincubated with osteogenic medium.
C and G: Low cell seeding density with cells preincubated without osteogenic medium. D and H: High cell seeding density with cells preincubated
without osteogenic medium. Although seeded at different densities and preincubated with and without osteogenic medium, all cells appear to be
flattened and well spread on the scaffolds. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
3652 YASSIN ET AL. COPOLYMER SCAFFOLDS INDUCED BONE REGENERATION
osteogenic medium compared with low cell seeding density
without osteogenic medium (p5 0.032). Moreover, from day
7 to day 21, Runx2 expression was signiﬁcantly upregulated
in scaffolds with high cell seeding density without osteo-
genic medium (p5 0.029) [Fig. 3(A)].
Col1 expression disclosed a signiﬁcant overall upregula-
tion effect of high cell seeding density (p5 0.009). There
were also signiﬁcant interactions between high cell density
and incubation time (p5 0.009) and osteogenic medium
and incubation time (p50.019). Pairwise comparison at
day 21 showed signiﬁcantly higher expression of Col1 for
scaffolds with high cell seeding density without osteogenic
medium than for low cell seeding density without osteo-
genic medium (p5 0.011) [Fig. 3(B)].
ALP expression was not overall signiﬁcantly affected by
high cell seeding density (p5 0.38) or osteogenic medium
(p50.69). Signiﬁcant relationships were disclosed between
osteogenic medium and incubation time (p< 0.001) and
among high cell seeding density, osteogenic medium, and
incubation time (p5 0.026). The pairwise comparison at
day 7 showed signiﬁcant upregulation of ALP associated
with high cell seeding density with osteogenic medium com-
pared with low cell seeding density with osteogenic medium
(p50.020). Similarly, high cell seeding density with osteo-
genic medium showed signiﬁcant upregulation of ALP
FIGURE 3. mRNA expression of (A) Runx2, (B) Col 1, (C) ALP, (D) BMP2, (E) BSP, and (F) OC by qRT-PCR, presented as x-fold changes relative to
the expression of the mean of the calibrator sample LD-OM. A: Runx2 expression is downregulated by osteogenic medium (p5 0.005) and
upregulated by high cell seeding density (p50.001). B: Col1 expression is upregulated by high cell seeding density (p5 0.001). C: ALP expres-
sion, disclosing a significant relationship between high cell density, osteogenic medium, and number of days (p5 0.026). D: BMP2 expression is
upregulated by osteogenic medium (p< 0.001) and high cell seeding density (p5 0.003). E: BSP expression is upregulated by osteogenic
medium (p< 0.001) and high cell seeding density (p5 0.033). F: OC expression is upregulated by osteogenic medium (p50.002) and high cell
seeding density (p5 0.013). The data are presented as means695% confidence intervals.
FIGURE 2. Total DNA quantification of cultured cell/scaffold constructs
(n5 4 for each group and time point). The data are presented as
means695% confidence intervals. The results indicate continued pro-
liferation of BMSCs for up to 3 weeks (p50.001) and a positive effect
of osteogenic supplements on cell proliferation (p< 0.001).
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compared with high cell seeding density without osteogenic
medium (p5 0.05). By day 21, ALP levels from scaffolds
with high cell seeding density without osteogenic medium
showed signiﬁcant upregulation compared with scaffolds
with high cell seeding density and osteogenic medium
(p50.021) [Fig. 3(C)].
BMP-2 expression was signiﬁcantly overall upregulated
in scaffolds with high cell seeding density (p50.003) and
osteogenic medium (p< 0.001). Signiﬁcant relationships
were disclosed between high cell seeding density and osteo-
genic medium (p5 0.047) and between osteogenic medium
and incubation time (p5 0.001). The pairwise comparison
at day 7 showed signiﬁcant upregulation of BMP-2 in low
cell seeding density with osteogenic medium compared with
low cell seeding density without osteogenic medium
(p50.013). In addition, expression of BMP-2 in high cell
seeding density with osteogenic medium was signiﬁcantly
upregulated compared with high cell seeding density with-
out osteogenic medium (p< 0.001) [Fig. 3(D)].
BSP expression showed signiﬁcant overall upregulation
in scaffolds with high cell seeding density (p50.033) and
osteogenic medium (p< 0.001). In addition, the interaction
between osteogenic medium and incubation time was signif-
icant (p< 0.001). Pairwise comparison at day 7 and day 21
showed signiﬁcant upregulation of BSP in low cell seeding
density with osteogenic medium compared with low cell
seeding density without osteogenic medium (p< 0.001) and
signiﬁcant upregulation of BSP in high cell seeding density
with osteogenic medium compared with high cell seeding
density without osteogenic medium (p< 0.001) [Fig. 3(E)].
OC expression exhibited a signiﬁcant overall upregula-
tion effect of high cell seeding density (p5 0.013) and
osteogenic medium (p5 0.002) [Fig. 3(F)].
lCT
Bone formation in the calvarial defects was evaluated at 8
weeks. In defects implanted with constructs seeded with
cells cultured at low density in nonosteogenic medium, heal-
ing was 14.27% (95% CI: 10.66, 17.88); the corresponding
rate for cells cultured at high density in nonosteogenic
medium was 14.46% (95% CI: 10.40, 18.51) (p5 0.99).
Healing of defects treated with cells preincubated in osteo-
genic medium was 13.43% (95% CI: 7.26, 19.61) for cells
cultured at low density and 21.71% (95% CI: 14.63, 28.79)
for those cultured at high density (p50.023). There was a
signiﬁcant interaction effect between high cell density and
osteogenic medium (p5 0.038) (Fig. 4).
Histology
Various levels of osteoid-like tissue formation are illustrated
in Figure 5. Compared with the other groups, more bone-
like tissue formed in the group implanted with constructs
containing cells cultured in osteogenic medium at high cell
seeding density.
DISCUSSION
The objectives of this study were to determine the initial
biological responses, the osteogenic potential, and the
induction of new bone in response to implanted poly(LLA-
co-CL) scaffolds seeded with two different densities of
FIGURE 4. Bone formation in critical-size rat calvarial defects. A: Three-dimensionally reconstructed high-resolution lCT image of defects
implanted with cells/scaffolds after 8 weeks of healing. Note the new bone formed in the four groups; with osteogenic medium (1OM) or with-
out osteogenic medium (2OM) with different densities of cell seeding (low density (LD) or high density (HD)). B: Quantification of percentage of
area and volume of bone regeneration in calvarial defects after 8 weeks of healing. Implantation of scaffolds containing cells seeded at high
density and cultured with osteogenic medium exhibit a significant percentage of bone volume (p50.038). [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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BMSCs. The effects of cell seeding density and pretreatment
of BMSCs with osteogenic supplements on cell proliferation,
differentiation, and bone formation were also assessed.
Moreover, a potential synergistic effect of these factors was
evaluated.
In the in vitro experiments, the cells were cultured
under dynamic cell culture conditions, using spinner-
modiﬁed ﬂasks. Previous studies show that the shear stress
induced by spinner ﬂasks regulates cellular physiological
activity through stimulation of mechano-transduction path-
ways and promotes in vitro cell proliferation and differentia-
tion.33,35,36 Further, the critical size cranial defect model is
well established for evaluating orthotopic implantation.
However, calvarial bone has a relatively poor blood supply
and relative lack of bone marrow, that is, conditions less
than ideal for bone formation.37
Interactions of BMSCs with their microenvironment play
an important role in their morphogenesis and differentia-
tion. An important component of the cell microenvironment
is the surrounding matrix, which includes several biophysi-
cal and chemical signals. These signals are recognized, inte-
grated, and processed by the cells to determine the
behavior and function of the engineered tissues. It has been
shown that ﬁbronectin, the extracellular protein present in
serum and plasma, is a major mediator of BMSC adhesion
to polymeric scaffolds.38 Thus, by controlling physical and
chemical characteristics of poly(LLA-co-CL) scaffolds, such
as solubility, degradation behavior, chemical composition,
crystallinity, and hydrophilicity, it is possible to regulate cell
survival, migration, proliferation, and differentiation during
the regeneration process.2,4,30,39
The number of cells capable of attaching to scaffolds
depends on the porosity, mean pore size, and surface area.
The porosity of poly(LLA-co-CL) scaffolds used in the cur-
rent experiments is about 85%, providing a large surface
area for cellular attachment and proliferation, conducive to
uniform cell distribution.40–42 In a previous study, co-
culturing BMSCs with endothelial cells at a density of 5 3
105 cells/scaffold resulted in low bone induction.32 Hence,
the number of cells was increased in this work. We
hypothesized that a large scaffold surface area containing
more attached cells would further stimulate bone formation.
Cell signaling can result either from direct cell2cell
communication or from secreted signaling molecules. With
high cell density, cell–cell communication and paracrine sig-
naling increase. Direct cell–cell communication via gap junc-
tions [i.e., gap junction intercellular communication (GJIC)]
is an important element promoting growth and differentia-
tion in various tissues.43 GJIC is mediated by connexins. In
particular, connexin 43 (Cx43) plays an important role in
regulating signal transmission among different bone cells.
Increased cell proliferation has been observed as a result of
connexin 43 stimulation.44 In this study, the in vitro data
generated at day 7 showed that high density seeding of the
copolymer scaffolds led to increased cell proliferation. This
stimulation is probably caused by GJIC activity. At day 21,
however, there was no correlation between cell proliferation
and cell seeding density, suggesting that maturation level
had been reached. A logarithmic relationship has been dem-
onstrated before between cell density and bone formation.13
The optimal cell density above which bone in-growth did
not change was identiﬁed, that is, increasing the cell num-
bers above this level did not stimulate more bone forma-
tion. This indicates that the direct cell–cell communication
through optimal cell seeding density and soluble osteogenic
factors might act as synergistic modulators in promoting
bone formation.
In animal studies, mesenchymal stem cells (MSCs) have
been reported to induce osteogenesis and have been used
extensively for regeneration of bone defects.29,45,46 The opti-
mal protocol for expanding MSCs in medium containing
osteogenic supplements may depend on the tissues from
which the MSCs were isolated; cells of different origin may
have inherited different degrees of osteogenicity.29,47,48
Osteoprogenitor cells can differentiate in the presence or
absence of osteogenic supplements.49 At least two classes of
osteoblast progenitor cells could be deﬁned: those differen-
tiating in the absence of osteogenic supplements and those
requiring the supplements to differentiate. In the absence,
few cells differentiate and these are only detectable after
cell numbers are increased.49 This hypothesis is supported
by the in vitro data of the present work which demonstrate
that after 21 days in the absence of osteogenic supplements,
an increase in cell density upregulates the expression of
FIGURE 5. Representative sections of Masson’s trichrome staining through calvarial defects at 8 weeks (310). A: Section of a defect implanted
with a scaffold containing cells cultured without osteogenic medium and seeded at low density, showing fibrous connective tissue and collagen.
B: Defect implanted with a scaffold containing cells cultured without osteogenic medium and seeded at high density, showing osteoid-like tissue
(green areas). C: Defect implanted with a scaffold containing cells cultured with osteogenic medium and seeded at low density, showing
osteoid-like tissue. D: Defect implanted with a scaffold containing cells cultured with osteogenic medium and seeded at high density, showing
formation of a bridge of bone-like tissue. Scale bar51000 lm. [Color figure can be viewed in the online issue, which is available at wileyonline-
library.com.]
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osteogenic markers Runx 2, COL1, and ALP. Accordingly, the
osteogenic differentiation of BMSCs might depend on the
cell density, culture condition, and time. However, when
MSCs are fully differentiated, their pluripotency and immu-
nosuppressibility may also decrease and this may impair
osteogenicity and bone formation.50
Osteogenic differentiation of BMSCs proceeds in three
stages: early or commitment to osteogenic differentiation,
matrix synthesis, and then the ﬁnal stage, mineralization.51 In
the osteoblastic differentiation model, cells proliferate rapidly
from 7 to 14 days and then start to secrete ECM proteins
and produce early differentiation markers such as ALP, which
is produced from day 7.52 Thereafter, as the cells mature,
proliferation decreases over time. In in vitro data of this
study, continued proliferation of BMSCs indicates that the
cells were still at the early maturation stage when the experi-
ments were conducted. mRNA expression of ALP was ﬁrst
upregulated at day 7 and then downregulated at day 21. ALP
expression is controlled by BMP2 through the Wnt/LRP5 sig-
naling cascade.53 BMP2 is known to participate in the regula-
tion of cell growth and differentiation, along with the
induction of osteogenic progenitor cells in bone defect sites
during the healing process. In the group with high cell seed-
ing density and osteogenic supplements, there was a general
decline of BMP2 expression at day 21, suggesting that the
BMSCs had entered a maturation stage of differentiation.
In this work, cells cultured at high density with osteo-
genic supplements demonstrated an increase and upregula-
tion of osteocalcin mRNA expression during the experimental
period. Osteocalcin is a late, speciﬁc marker of osteoblast
maturation.54 This is in agreement with a previous report
showing that an increase in cell numbers in the presence of
osteogenic supplements upregulated osteocalcin expression
and maturation of osteoblasts.12 A correlation may exist
between increased extracellular protein secretion and an
increased number of mature osteoblasts, leading to promo-
tion of bone formation. Our in vivo data conﬁrmed his obser-
vation demonstrating more bone formation in response to an
increase in the number of expanded and differentiated cells.
Accordingly, the present results indicate that the number of
mature osteoblast determined the rate of bone formation.
The in vivo ﬁndings demonstrate synergistic stimulation
of cell seeding density and osteogenic supplements on bone
formation. Dex is a synthetic glucocorticoid reported to be an
essential requirement for osteoprogenitor cell differentiation
of MSCs in vitro. The mechanism of action of dex on BMSCs
can be through induced transcription of BSP by binding on a
glucocorticoid response element in the promoter region of
the BSP gene, which is associated with osteoblast differentia-
tion.55 This was veriﬁed in vitro by BSP mRNA expression.
BSP is an indicator of cellular maturation. On the other hand,
osteogenic differentiation of BMSCs was clearly inﬂuenced by
the initial seeding densities via cell–cell communication.
Thus, both factors may accelerate osteoblastic differentiation,
leading primarily to more mature osteoblasts and secondarily
to more bone formation.
Although the in vivo data clearly conﬁrm new bone for-
mation, the lCT images and histology at 8 weeks did not
show complete healing and bone regeneration. In bone TE,
the transplanted scaffold should act as a temporary ECM
substitute, stimulating cell attachment, proliferation, and dif-
ferentiation, with subsequent bone in-growth until ﬁnally
being completely degraded and replaced by regenerated
bone. Scaffold degradation should be adjusted appropriately
to the rate of neobone formation,56 thus allowing the
mechanical load on the scaffold to be transferred gradually
to the regenerated tissue. Finally, when total tissue regener-
ation has been achieved, the scaffold should be completely
degraded.
A previous in vivo study using similar scaffolds showed
slow, gradual degradation of the poly(LLA-co-Cl) scaffolds
within 91 days of the experimental period.4 The delayed
degradation of the scaffolds might suggest a longer healing
process in this experimental model.
CONCLUSIONS
The induction of new bone in a critical size defect indicates
that poly(LLA-co-CL) scaffolds are appropriate candidates
for constructs in bone TE. Bone regeneration might depend
on cell–cell communication, which is an important element
promoting growth and differentiation in various tissues. The
appropriate number of cells to be loaded onto a speciﬁc
scaffold is a critical, vital factor for promoting ECM synthe-
sis and bone formation. This study demonstrates that
increasing cell numbers seeded onto poly(LLA-co-Cl) scaf-
folds promote BMSCs differentiation and bone formation.
Osteogenic supplements are key determinants of the ability
of MSCs to induce new bone tissue formation. Thus, the syn-
ergistic effect of cell density and osteogenic supplements
appears to be of major importance in bone formation.
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